| pubmed-article:6817771 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6817771 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:6817771 | lifeskim:mentions | umls-concept:C0020155 | lld:lifeskim |
| pubmed-article:6817771 | lifeskim:mentions | umls-concept:C0085228 | lld:lifeskim |
| pubmed-article:6817771 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6817771 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:6817771 | lifeskim:mentions | umls-concept:C0055961 | lld:lifeskim |
| pubmed-article:6817771 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:6817771 | pubmed:dateCreated | 1983-3-11 | lld:pubmed |
| pubmed-article:6817771 | pubmed:abstractText | 1 Fluvoxamine and clovoxamine, two new potential antidepressants were given to 27 healthy male volunteers in a double-blind, placebo controlled, three-way crossover study. 2 Neither compound affected the electrical intervals of 24 h ambulant electrocardiographic monitoring with the exception of a small increase in R-R interval. 3 There were no changes in blood pressure measurements. 4 The only notable unwanted symptom was nausea for both fluvoxamine and clovoxamine. | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6817771 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6817771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6817771 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6817771 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:6817771 | pubmed:issn | 0306-5251 | lld:pubmed |
| pubmed-article:6817771 | pubmed:author | pubmed-author:RobinsonJ FJF | lld:pubmed |
| pubmed-article:6817771 | pubmed:author | pubmed-author:DooganD PDP | lld:pubmed |
| pubmed-article:6817771 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6817771 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:6817771 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6817771 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6817771 | pubmed:pagination | 805-8 | lld:pubmed |
| pubmed-article:6817771 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:meshHeading | pubmed-meshheading:6817771-... | lld:pubmed |
| pubmed-article:6817771 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6817771 | pubmed:articleTitle | A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers. | lld:pubmed |
| pubmed-article:6817771 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6817771 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:6817771 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6817771 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6817771 | lld:pubmed |
